Dritan Hasa
Impact in
-
- Crystallography and molecular interactions
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Crystallization and Solubility Studies 19
- X-ray Diffraction in Crystallography 6
-
- Crystallography and molecular interactions 20
- Co-authors
- William Jones (10 shared papers)Dario Voinovich (36 shared papers)Gabriela Schneider Rauber (5 shared papers)Beatrice Perissutti (28 shared papers)Elvio Carlino (4 shared papers)Michele R. Chierotti (13 shared papers)Mario Grassi (14 shared papers)Roberto Gobetto (6 shared papers)
- Journals
- Crystal Growth & Design (7 papers)International Journal of Pharmaceutics (6 papers)European Journal of Pharmaceutics and Biopharmaceutics (6 papers)CrystEngComm (3 papers)Molecular Pharmaceutics (3 papers)
- Partner nations
- ItalyUnited KingdomSlovenia
In The Last Decade
Dritan Hasa
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Physical and Theoretical Chemistry 586
- Pharmaceutical Science 261
- Materials Chemistry 692
- Pharmacology 99
- Spectroscopy 137
Countries citing papers authored by Dritan Hasa
This map shows the geographic impact of Dritan Hasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dritan Hasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dritan Hasa more than expected).
Fields of papers citing papers by Dritan Hasa
This network shows the impact of papers produced by Dritan Hasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dritan Hasa. The network helps show where Dritan Hasa may publish in the future.
Co-authors
The 25 scholars most cited alongside Dritan Hasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 192 | |
| 2 | 2017 | 169 | |
| 3 | 2016 | 111 | |
| 4 | 2016 | 88 | |
| 5 | 2019 | 59 | |
| 6 | 2018 | 53 | |
| 7 | 2015 | 49 | |
| 8 | 2010 | 42 | |
| 9 | 2021 | 38 | |
| 10 | 2012 | 37 | |
| 11 | 2011 | 31 | |
| 12 | 2013 | 31 | |
| 13 | 2011 | 29 | |
| 14 | 2020 | 25 | |
| 15 | 2012 | 24 | |
| 16 | 2017 | 24 | |
| 17 | 2018 | 23 | |
| 18 | 2010 | 20 | |
| 19 | 2019 | 19 | |
| 20 | 2011 | 17 |
About Dritan Hasa
Dritan Hasa is a scholar working on Materials Chemistry, Physical and Theoretical Chemistry, Pharmaceutical Science, Molecular Biology and Pharmacology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Crystallography and molecular interactions (20 papers), Crystallization and Solubility Studies (19 papers), Drug Solubulity and Delivery Systems (14 papers), Advancements in Transdermal Drug Delivery (6 papers), X-ray Diffraction in Crystallography (6 papers), Advanced Drug Delivery Systems (5 papers), Plant-based Medicinal Research (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Physical and Theoretical Chemistry (586 citations), Pharmaceutical Science (261 citations), Materials Chemistry (692 citations), Pharmacology (99 citations) and Spectroscopy (137 citations). Dritan Hasa has collaborated with scholars based in Italy, United Kingdom and Slovenia. Frequent co-authors include William Jones, Dario Voinovich, Gabriela Schneider Rauber, Beatrice Perissutti, Elvio Carlino, Michele R. Chierotti, Mario Grassi, Roberto Gobetto, Iztok Grabnar and Mihails Arhangelskis. Their work appears in journals such as Crystal Growth & Design, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, CrystEngComm and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.